On December 19, 2016 10:25 (IST)
Laurus Labs makes active pharmaceutical ingredients or APIs that go into the making a range of medicines, chiefly HIV/AIDS drugs.
On December 08, 2016 16:15 (IST)
Laurus Labs was selling up to Rs 300 crore in new shares and some its shareholders were selling about 24.1 million shares in a price range of Rs 426 to Rs 428 per share.
On December 06, 2016 10:20 (IST)
The anchor investors included Goldman Sachs India, Nomura Trust and Banking, SBI Mutual Fund, DSP BlackRock and ICICI Prudential Mutual Fund.